Arena Pharmaceuticals, Inc. (ARNA)
-NasdaqGS 7.99
0.03(0.38%) 4:00PM EDT|After Hours
:
7.98
0.01 (0.13%) 6:04PM EDT
| Prev Close: | 7.96 |
|---|
| Open: | 7.97 |
|---|
| Bid: | 7.80 x 5000 |
|---|
| Ask: | 8.33 x 100 |
|---|
| 1y Target Est: | 8.36 |
|---|
| Beta: | -0.54 |
|---|
| Next Earnings Date: | 7-Aug-13 |
|---|
| Day's Range: | 7.94 - 8.04 |
|---|
| 52wk Range: | 5.78 - 13.50 |
|---|
| Volume: | 2,712,212 |
|---|
| Avg Vol (3m): | 5,350,210 |
|---|
| Market Cap: | 1.74B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.37 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 62.42 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.14 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.12 |
|---|
| Mean Recommendation*: | 2.7 |
|---|
| PEG Ratio (5 yr expected): | -2.29 |
|---|
Business Summary
Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory,...
View More